A Study to Collect Tissue Samples from Patients with Myeloproliferative Neoplasms, to Perform a Variety of Biomarker Studies

Overview

About this study

The purpose of this study is to collect and store tissue samples from patients who have myeloproliferative tumors, to be used to perform a variety of biomarker studies monitoring the effects of particular treatments.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

Meet the eligibility criteria for one of the MPD-RC treatment protocols linked to this study
Diagnosed with a Myeloproliferative disorder including
- Polycythemia vera
- Idiopathic myelofibrosis
- Essential thrombocythemia
Signed an informed consent to participate in a Myeloproliferative Disorders Research Consortium (MPD-RC) treatment study to which this protocol is a companion study
Signed a consent to participate in this mandatory companion study

Exclusion Criteria

See inclusion criteria

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Scottsdale/Phoenix, Ariz. Mayo Clinic principal investigator Jeanne Palmer, M.D.	Closed for enrollment	Contact information: Cancer Center Clinical Trials Referral Office 855-776-0015

Mayo Clinic Location

Status

Contact

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Jeanne Palmer, M.D.

Closed for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

855-776-0015

More information

Publications

Publications are currently not available

Clinical Trials